The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Davis J. E. since 2018.
This trader's CIK number is 1599837.
At the time of last reporting, Davis J. E. was the CEO and President of Quest Diagnostics Inc. (stock ticker symbol DGX).
Also see all insider trading activities at Quest Diagnostics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DGX | 0 | $0 | 39,191 | $6,613,089 | 0 | $0 |
| 2020 | DGX | 0 | $0 | 149,258 | $15,764,721 | 143,546 | $9,881,706 |
| 2019 | DGX | 0 | $0 | 55,574 | $5,242,922 | 47,574 | $2,886,552 |
| 2018 | DGX | 0 | $0 | 71,294 | $7,059,182 | 63,880 | $3,332,300 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-02 | DGX | Sale | 39,191 | 168.74 | 6,613,089 |
| 2020-03-16 | DGX | Sale | 3,513 | 87.75 | 308,251 |
| 2020-02-26 | DGX | Sale | 510 | 111.09 | 56,655 |
| 2020-02-27 | DGX | Sale | 1,100 | 109.02 | 119,922 |
| 2020-02-25 | DGX | Sale | 598 | 112.73 | 67,412 |
| 2020-01-02 | DGX | Sale | 143,537 | 105.98 | 15,212,481 |
| 2020-01-02 | DGX | Option Ex | 143,546 | 68.84 | 9,881,706 |
| 2019-04-24 | DGX | Option Ex | 47,574 | 60.67 | 2,886,552 |
| 2019-04-24 | DGX | Sale | 47,574 | 95.00 | 4,519,530 |
| 2019-04-08 | DGX | Sale | 8,000 | 90.42 | 723,392 |
| 2018-03-05 | DGX | Sale | 5,122 | 101.00 | 517,322 |
| 2018-02-27 | DGX | Sale | 1,150 | 104.10 | 119,715 |
| 2018-02-28 | DGX | Sale | 648 | 104.99 | 68,033 |
| 2018-02-26 | DGX | Sale | 494 | 102.74 | 50,753 |
| 2018-01-02 | DGX | Option Ex | 63,880 | 52.16 | 3,332,300 |
| 2018-01-02 | DGX | Sale | 63,880 | 98.67 | 6,303,359 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Davis J. E. (CEO and President of Quest Diagnostics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.